New French relative assessment method for drug reimbursement has echoes of German system
This article was originally published in SRA
Executive Summary
The French health technology assessment agency, the HAS (Haute Autorité de Santé), has published details of a new "relative therapeutic index" mechanism that it plans to use to select medicines for reimbursement on the basis of a comparison with existing products1.